(Q38046115)

27 August 2017

title

Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes (English)

1 reference

27 August 2017

4

Morgan Rouprêt

1 reference

27 August 2017

François Audenet

1

1 reference

27 August 2017

Olivier Traxer

series ordinal

2

1 reference

27 August 2017

Karim Bensalah

series ordinal

3

1 reference

27 August 2017

publication date

25 September 2012

1 reference

27 August 2017

published in

World Journal of Urology

1 reference

27 August 2017

volume

31

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

45-52

1 reference

27 August 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Bacillus Calmette-Guérin for upper tract urothelial cancer: is there a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Specific binding of bacillus Calmette-Guérin to urothelial tumor cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Primary percutaneous approach to upper urinary tract transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guérin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0949-3

Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter

21 January 2018

1 reference

12 December 2020

Percutaneous management of renal pelvic tumors: a treatment option in selected cases

1 reference

12 December 2020

Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.

1 reference

12 December 2020

Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma

1 reference

12 December 2020

Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B

1 reference

12 December 2020

Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience

1 reference

12 December 2020

Instillation of bacillus Calmette-Guerin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma

1 reference

12 December 2020

Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.

1 reference

12 December 2020

13-year experience with percutaneous management of upper tract transitional cell carcinoma

1 reference

12 December 2020

Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ

1 reference

12 December 2020

Percutaneous treatment of transitional cell carcinoma of the upper urinary tract.

1 reference

12 December 2020

Adjuvant topical treatment of upper urinary tract urothelial tumours

1 reference

12 December 2020

Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies

1 reference

12 December 2020

Local excision and topical thiotepa in the treatment of transitional cell carcinoma of the renal pelvis: a case report

1 reference

12 December 2020

Complications of intracavitary bacillus Calmette-Guerin after percutaneous resection of upper tract transitional cell carcinoma

1 reference

12 December 2020

Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys

1 reference

12 December 2020

Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors

1 reference

12 December 2020

Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma

1 reference

12 December 2020

Definitive tumor resection and percutaneous bacille Calmette-Guérin for management of renal pelvic transitional cell carcinoma in solitary kidneys

1 reference

12 December 2020

Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin.

1 reference

12 December 2020

Treatment of urothelial carcinoma of the upper urinary tract following prostatocystectomy with mitomycin C instillation in the ileal loop

1 reference

12 December 2020

Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract

1 reference

12 December 2020

Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract

1 reference

12 December 2020

Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma

1 reference

12 December 2020

Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials

1 reference

12 December 2020

Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)

1 reference

12 December 2020

The effect of bacillus Calmette-Guerin on the urinary system of pigs

1 reference

12 December 2020

Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure

1 reference

12 December 2020

Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.

1 reference

12 December 2020

Ureteroscopic management of transitional cell carcinoma of the upper urinary tract.

1 reference

12 December 2020

Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors

1 reference

12 December 2020

The management of transitional cell carcinoma in solitary renal units

1 reference

12 December 2020

10.1007/S00345-012-0949-3

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1031133685

0 references

1 reference